Population Pharmacokinetics of High Dose Continuous Infusion Meropenem and Considerations for the Use in the Treatment of Infections Due to KPC-Producing Klebsiella Pneumoniae
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00794-17
Full Text
Open PDFAbstract
Available in full text
Date
July 31, 2017
Authors
Publisher
American Society for Microbiology